118 related articles for article (PubMed ID: 29345837)
1. Regulation and regulatory parameters of histone modifications.
Davie JR; Chadee DN
J Cell Biochem; 1998; 72 Suppl 30-31(S30-31):203-213. PubMed ID: 29345837
[TBL] [Abstract][Full Text] [Related]
2. Regulation and regulatory parameters of histone modifications.
Davie JR; Chadee DN
J Cell Biochem Suppl; 1998; 30-31():203-13. PubMed ID: 9893272
[TBL] [Abstract][Full Text] [Related]
3. Control of histone modifications.
Davie JR; Spencer VA
J Cell Biochem; 1999; Suppl 32-33():141-8. PubMed ID: 10629113
[TBL] [Abstract][Full Text] [Related]
4. Covalent modifications of histones: expression from chromatin templates.
Davie JR
Curr Opin Genet Dev; 1998 Apr; 8(2):173-8. PubMed ID: 9610407
[TBL] [Abstract][Full Text] [Related]
5. Role of histone deacetylases in acute leukemia.
Fenrick R; Hiebert SW
J Cell Biochem; 1998; 72 Suppl 30-31(S30-31):194-202. PubMed ID: 29345812
[TBL] [Abstract][Full Text] [Related]
6. A feed-forward repression mechanism anchors the Sin3/histone deacetylase and N-CoR/SMRT corepressors on chromatin.
Vermeulen M; Walter W; Le Guezennec X; Kim J; Edayathumangalam RS; Lasonder E; Luger K; Roeder RG; Logie C; Berger SL; Stunnenberg HG
Mol Cell Biol; 2006 Jul; 26(14):5226-36. PubMed ID: 16809761
[TBL] [Abstract][Full Text] [Related]
7. Regulation of NuA4 histone acetyltransferase activity in transcription and DNA repair by phosphorylation of histone H4.
Utley RT; Lacoste N; Jobin-Robitaille O; Allard S; Côté J
Mol Cell Biol; 2005 Sep; 25(18):8179-90. PubMed ID: 16135807
[TBL] [Abstract][Full Text] [Related]
8. Roles of histone acetyltransferases and deacetylases in gene regulation.
Kuo MH; Allis CD
Bioessays; 1998 Aug; 20(8):615-26. PubMed ID: 9780836
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptors, their coactivators and modulation of transcription.
Manteuffel-Cymborowska M
Acta Biochim Pol; 1999; 46(1):77-89. PubMed ID: 10453983
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
11. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
Aoyagi S; Archer TK
Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
[TBL] [Abstract][Full Text] [Related]
12. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
13. Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression.
Li J; Lin Q; Wang W; Wade P; Wong J
Genes Dev; 2002 Mar; 16(6):687-92. PubMed ID: 11914274
[TBL] [Abstract][Full Text] [Related]
14. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.
Guidez F; Howell L; Isalan M; Cebrat M; Alani RM; Ivins S; Hormaeche I; McConnell MJ; Pierce S; Cole PA; Licht J; Zelent A
Mol Cell Biol; 2005 Jul; 25(13):5552-66. PubMed ID: 15964811
[TBL] [Abstract][Full Text] [Related]
15. Avian erythroleukemia: a model for corepressor function in cancer.
Rietveld LE; Caldenhoven E; Stunnenberg HG
Oncogene; 2001 May; 20(24):3100-9. PubMed ID: 11420726
[TBL] [Abstract][Full Text] [Related]
16. Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression.
Illi B; Nanni S; Scopece A; Farsetti A; Biglioli P; Capogrossi MC; Gaetano C
Circ Res; 2003 Jul; 93(2):155-61. PubMed ID: 12805238
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors--a new tool to treat cancer.
Somech R; Izraeli S; J Simon A
Cancer Treat Rev; 2004 Aug; 30(5):461-72. PubMed ID: 15245778
[TBL] [Abstract][Full Text] [Related]
18. Control of cardiac growth by histone acetylation/deacetylation.
Backs J; Olson EN
Circ Res; 2006 Jan; 98(1):15-24. PubMed ID: 16397154
[TBL] [Abstract][Full Text] [Related]
19. Histone modification enzymes: novel targets for cancer drugs.
Kristeleit R; Stimson L; Workman P; Aherne W
Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic control of ovarian function: the emerging role of histone modifications.
LaVoie HA
Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
